AUTOLITIND

AUTOLITIND:The Exchange has sought clarification from Autolite (India) Limited with respect to announcement dated 03-Jun-2019, regarding Board meeting held on May 30, 2019. On basis of above the Company is required to clarify following: 1. Disclosure of relationships between directors (in case of appointment of a director)2. Brief profile (in case of appointment)The response of the Company is awaited.

Significant movement in price has been observed in Autolite (India) Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Autolite (India) Limited has submitted their response.

Significant movement in price has been observed in Autolite (India) Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

AUTOLITIND:The Exchange had sought clarification from Autolite (India) Limited with respect to announcement dated 14-Aug-2018, regarding " Autolite (India) Limited has informed the Exchange regarding Appointment of Mr Rajeev Maheshwari as Non- Executive Independent Director of the company w.e.f. August 14, 2018.".On basis of above the Company is required to clarify following:1. Brief profile (in case of appointment);<br>2. Date of appointment/cessation (as applicable) & term of appointment;<br>The response of the Company is attached.

AUTOLITIND:The Exchange has sought clarification from Autolite (India) Limited with respect to announcement dated 14-Aug-2018, regarding " Autolite (India) Limited has informed the Exchange regarding Appointment of Mr Rajeev Maheshwari as Non- Executive Independent Director of the company w.e.f. August 14, 2018.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);<br> 2. Date of appointment/cessation (as applicable) & term of appointment;<br> The response of the Company is awaited.